RG7314: Phase II started

Roche disclosed in its 3Q13 earnings that it began a double-blind, placebo-controlled Phase II

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE